🔗 Permalink

Inventor profile of:

Michael Diamond

City:

St. Louis, Missouri

Country:

United States

Published Applications:

Last publication date:

2026-04-09

Top Assignees for applications by Michael Diamond

The entities that hold a legal rights for patent applications filed by inventor Diamond Michael:

Washington University 13 St. Louis, MO United States
Oregon Health & Science University 1 Portland, OR United States
The Board of Regents of the University of Texas System 1 Austin, TX United States
Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung e.V. 1 Munchen, Germany
Washington University in St. Louis 1 St. Louis, LA United States
SOUTHERN RESEARCH INSTITUTE 1 Birmingham, AL United States
THE CLEVELAND CLINIC FOUNDATION 1 Cleveland, OH United States
Board of Regents, The University of Texas System 1 Austin, TX United States

Recent patent applications by Diamond Michael

Michael Diamond from St. Louis, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-09

US20260098073A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITION OF E. COLI HEMOLYSIN DURING URINARY TRACT INFECTION

#2 | 2026-03-05

US20260062466A1

Chemistry; metallurgy

ALPHAVIRUS ANTIGEN BINDING ANTIBODIES AND USES THEREOF

#3 | 2025-07-31

US20250243251A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TARGETING MXRA8 TO TREAT OBESITY AND ASSOCIATED METABOLIC DISEASES

#4 | 2025-04-03

US20250109199A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR VLDLR-BASED DECOY RECEPTORS AGAINST ALPHAVIRUSES

#5 | 2024-04-18

US20240124553A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITION OF ALPHAVIRUS INFECTION

#6 | 2024-04-11

US20240116972A1

Chemistry; metallurgy

6-AZA-NUCLEOSIDE PRODRUGS AS ANTIVIRAL AGENTS FOR TREATING VIRUS INFECTIONS

#7 | 2023-11-02

US20230346919A1

Human necessities

SARS COV-2 VACCINES AND HIGH THROUGHPUT SCREENING ASSAYS BASED ON VESICULAR STOMATITIS VIRUS VECTORS

#8 | 2023-07-20

US20230227848A1

Chemistry; metallurgy

CORONAVIRUS VACCINE CONSTRUCTS AND METHODS OF MAKING AND USING SAME

#9 | 2023-06-15

US20230183338A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITING VIRAL RECOGNITION SITES

#10 | 2022-10-27

US20220340658A1

Chemistry; metallurgy

NEUTRALIZING ANTI-SARS-CoV-2 ANTIBODIES AND USE THEREOF

#11 | 2022-06-30

US20220204545A1

Chemistry; metallurgy

6-aza-nucleoside prodrugs as antiviral agents for treating virus infections

#12 | 2022-01-20

US20220017604A1

Chemistry; metallurgy

ANTI-SARS-CoV-2 MONOCLONAL ANTIBODIES

#13 | 2021-05-20

US20210145907A1

Human necessities

Zika virus strains for treatment of glioma

#14 | 2020-12-31

US20200407401A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITION OF ALPHAVIRUS INFECTION

#15 | 2017-04-13

US20170101642A1

Chemistry; metallurgy

METHODS OF INHIBITING VIRAL REPLICATION COMPRISING THE SIGNAL PEPTIDASE COMPLEX

#16 | 2017-03-30

US20170089897A1

Physics

Distinguishing flavivirus infection using a recombinant mutant envelope protein

#17 | 2012-03-29

US20120076758A1

Chemistry; metallurgy

ANTIBODIES AGAINST WEST NILE VIRUS AND THERAPEUTIC AND PROPHYLACTIC USES THEREOF

#18 | 2009-10-15

US20090258011A1

Chemistry; metallurgy

Antibodies against West Nile Virus and therapeutic and prophylactic uses thereof

#19 | 2006-06-01

US20060115837A1

Chemistry; metallurgy

Crystals and structure of domain III of West Nile Virus envelope protein in association with a Fab fragment of a neutralizing antibody

#20 | 2006-03-30

US20060067940A1

Chemistry; metallurgy

Antibodies against West Nile Virus and therapeutic and prophylactic uses thereof

InventorID:

1837302 ⎘